Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the detection, extraction, cryopreservation, archiving, and storage of umbilical cord blood, placental and umbilical cord mesenchymal stem cells, adult peripheral blood stem cells, and immune cells. It also provides cell cryopreservation services. The company was founded in 2001 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Meribank Biotech Co., Ltd (4724) operate in?
Meribank Biotech Co., Ltd belongs to the Other sector and operates in the Biotechnology industry.
What is Meribank Biotech Co., Ltd (4724) current stock price?
As of the latest data, Meribank Biotech Co., Ltd stock price is NT$8.91, with a previous close of NT$8.94. Meribank Biotech Co., Ltd lost -NT$0.03 in the last trading session, representing a -0.34% loss.
What is Meribank Biotech Co., Ltd (4724) current market capitalization?
Meribank Biotech Co., Ltd market cap is approximately 855.15 million.
What is Meribank Biotech Co., Ltd (4724) Earnings Per Share (EPS)?
The trailing EPS is -NT$0.89.
Does Meribank Biotech Co., Ltd (4724) pay dividends?
No. Meribank Biotech Co., Ltd does not pay a dividend.
What is Meribank Biotech Co., Ltd (4724) beta (volatility) score?
Meribank Biotech Co., Ltd has a beta of 0.410, indicating lower volatility than the overall market.